Long-term nonsteroidal anti-inflammatory drug use and gastroduodenal injury: The role of Helicobacter pylori

Gastroenterology

Volumn 102, Issue 6, 1992, Pages 1899-1905

  Loeb, David S ^a   Talley, Nicholas J ^a   Ahlquist, David A ^a   Carpenter, Herschel A ^a   Zinsmeister, Alan R ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; DICLOFENAC; IBUPROFEN; KETOPROFEN; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PIROXICAM; TOLMETIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG USE; DYSPEPSIA; ENDOSCOPY; FEMALE; GASTRITIS; GASTRODUODENAL ULCER; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; STOMACH BIOPSY; STOMACH MUCOSA LESION; UNITED STATES;

ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRITIS, RHEUMATOID; DUODENUM; FEMALE; GASTRIC MUCOSA; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMAN; MALE; MIDDLE AGE; PEPTIC ULCER; SUPPORT, NON-U.S. GOV'T;

EID: 0026532820     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1016/0016-5085(92)90311-L     Document Type: Article

References (31)

1. Silent peptic ulceration: Deadly silence or golden silence?
2. Nonsteroidal anti-inflammatory drug gastropathy: Recognition and response
3. Gastroduodenal complications of chronic NSAID therapy
4. The relationship between nonsteroidal anti-inflammatory drug use and peptic ulcer disease
5. Rising frequency of ulcer perforation in elderly people in the United Kingdom
6. Nonsteroidal anti-inflammatory drugs and hospitalization for gastroesophageal bleeding in the elderly
7. Transfer of Campylobacter pylori and Campylobacter mustelae to Helicobacter gen. nov. as Helicobacter pylori comb. nov. and Helicobacter mustelae comb. nov., respectively
8. Pyloric Campylobacter infection and gastroduodenal disease
9. Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori
10. Helicobacter pylori: controversies and an approach to management
11. Prevalence of Helicobacter pylori infection and histologic gastritis in asymptomatic persons
12. 2 production in vitro
13. Campylobacter pylori, NSAIDs, and smoking: risk factors for peptic ulcer disease
14. Campylobacter pylori associated gastritis in patients with rheumatoid arthritis taking nonsteroidal antiinflammatory drugs
15. Campylobacter-like organisms, nonsteroidal anti-inflammatory drugs and gastric lesions in patients with rheumatoid arthritis
16. Long-term nonsteroidal antiinflammatory drug use and Helicobacter pylori infection
17. Serological evidence of infection with Helicobacter pylori may predict gastrointestinal intolerance to nonsteroidal antiinflammatory drug treatment in rheumatoid arthritis
18. The presence of Campylobacter pylori in nonsteroidal antiinflammatory drug associated gastritis
19. Effect of long-term freezer storage, thawing, and refreezing on selected constituents of serum
20. Multisystem complaints in patients with the irritable bowel syndrome and functional dyspepsia
21. An endoscopic evaluation of the effects of non-steroidal anti-inflammatory drugs on the gastric mucosa
22. 14C] urea breath test for diagnosis of Helicobacter pylori
23. Campylobacter pylori antibodies in humans
24. Serodiagnosis of Helicobacter pylori: Comparison of enzyme-linked immunosorbent assays
25. Campylobacter pylori, mucus, and peptic ulceration: a dynamic interaction
26. Effect of Helicobacter pylori infection on the severity of gastroduodenal mucosal injury after the acute administration of naproxen or aspirin to normal volunteers
27. Treatment of endoscopy negative NSAID-induced upper gastrointestinal symptoms with cimetidine—an international multicenter collaborative study
28. Frequency of gastroduodenal lesions in asymptomatic patients on chronic aspirin or nonsteroidal anti-inflammatory drug therapy
29. Management of gastroduodenopathy associated with use of nonsteroidal anti-inflammatory drugs
30. Epidemiology of Helicobacter pylori in an asymptomatic population in the United States. Effect of age, race and socioeconomic status
31. Water sources as risk factor for Helicobacter pylori infection in Peruvian children